Objective: HIV-exposed uninfected (HEU) infants have higher infectious disease morbidity and mortality than unexposed infants. We determined the incidence and risk factors for pneumonia, a leading cause of infant mortality worldwide, in a cohort of HEU infants. Identifying predictors of pneumonia among HEU infants may enable early identification of those at highest risk.
Introduction
As increasingly effective measures to prevent infant HIV infection are implemented, the population of HIVexposed uninfected (HEU) infants is growing. HEU infants have higher mortality and morbidity than unexposed infants [1, 2] ; this may be due to increased exposure to infectious pathogens, impaired maternal care-giving, reduced breastfeeding, or compromised immune development [3] .
Pneumonia is a leading cause of child mortality [4] . Annual incidence of pneumonia in the developing world among children under 5 is estimated at 29/100 [4, 5] , with about 10% requiring hospitalization [4] . Approximately 50% of childhood pneumonias are caused by Haemophilus influenzae or Streptococcus pneumoniae [4] . Viral and mixed viral-bacterial infections are also common causes of childhood pneumonia in developing countries [6, 7] . HIV-infected children are at particularly high risk for pneumonia [6, 8] ; in a perinatal HIV cohort in Kenya, we previously found pneumonia to be the leading cause of mortality among both HEU [9] and HIV-infected infants [10] .
Elucidation of cofactors for pneumonia in HEU may inform interventions to prevent pneumonia or identification of mother-infant pairs at highest risk. In this study, we describe the incidence and predictors for pneumonia in a cohort of Kenyan HEU infants.
Methods

Participant selection
Mother-infant pairs were enrolled in a study of HIV transmission in Nairobi, Kenya, between 1999 and 2002, details of which have been described elsewhere [9, 11] . HEU infants were followed until 12 months of age. Singletons and first-born twins were eligible for this analysis if they were confirmed HIV-uninfected at birth. Infants were excluded if they died or were lost to follow-up (LTFU) without completing a study visit, or if they were HIV-infected in utero or during delivery.
Study procedures
The study was approved by the Institutional Review Board at the University of Washington and the Ethics and Research Committee at Kenyatta National Hospital. Sociodemographic information was collected at enrollment, and maternal CD4 þ T-cell percentage (CD4%) and HIV viral load were measured at 32 weeks' gestation. Mothers received antenatal short-course zidovudine for prevention of mother-to-child transmission (PMTCT), but no antiretroviral therapy (ART) during breastfeeding, as per contemporary Kenyan guidelines. Study visits occurred at birth, 2 weeks after delivery and monthly thereafter.
Clinical data collection
At scheduled visits, infants underwent detailed clinical examination by a physician. Symptoms, diagnoses, history of illness and hospitalization since the last visit, and current feeding practices were collected on a standardized form. At sick-child visits, examination and history were limited to features related to the infant's reporting complaint. For infants who died outside hospital, verbal autopsy was conducted to determine the most likely cause of death.
Outcome
Pneumonia was diagnosed according to Integrated Management of Childhood Illness (IMCI) guidelines. Diagnoses made at study visits, sick-child visits, or recorded as cause of death were included in this analysis. To rule out data entry error, diagnoses recorded at study visits were checked for the presence of IMCI pneumonia symptoms. To avoid double-counting an unresolved episode, new diagnoses were not counted for 14 days following each diagnosis.
Statistical analysis
Analyses were conducted using Stata 11.2 (StataCorp, College Station, Texas, USA). Infant growth was assessed using the WHO Child Growth Standards Stata igrowup package.
Incidence of all pneumonia, in the whole cohort and within strata of predictors, was calculated with censoring at non-pneumonia death, LTFU, last negative HIV-DNA before first HIV-DNA detection in HIV-infected infants, or study exit at 12 months. Infants did not contribute person-time for 14 days following a pneumonia diagnosis. Incidence of pneumonia-related hospitalization (allowing repeat hospitalizations) and pneumonia-related mortality was calculated the same way.
Predictors of first pneumonia diagnosis were identified using Cox proportional hazards regression with censoring as above. All exposures were assessed at baseline except maternal viral load, CD4%, breastfeeding, and weight-for-age Z-score (WAZ). Viral load and CD4% were measured at 32 weeks' gestation; breastfeeding (ever/never, current) and WAZ were assessed at each study visit and analyzed as time-varying covariates.
In order to address whether associations with breastfeeding were mediated through infant growth, breastfeeding and lagged WAZ were included in the same model. Other models of the association between breastfeeding and pneumonia were adjusted for maternal viral load or CD4% to assess confounding by advanced maternal disease.
Results
Study population
Three hundred and eighty-eight infants were included in this analysis; 365 remained uninfected, whereas 23 acquired HIV at a median of 33 days [interquartile range (IQR) . Eighty-five infants were LTFU at a median of 243 days (IQR 105-320). Mothers were mostly young (median 25 years, IQR 22-28), married (90%), lived in one-room houses (78%), and lacked an independent income (70%). At 32 weeks' gestation, mothers' median CD4 þ cell count was 438 cells/ml (IQR 310-611), median CD4% was 24 (IQR 18-30), and median viral load was 4.7 log 10 copies/ml (IQR 4.1-5.2). Seventy-six percent of mothers breastfed for a median of 273 days (IQR 123-364).
Pneumonia burden
Infants completed 328 person-years of follow-up. One hundred and seventy-seven infants were diagnosed with pneumonia ( Fig. 1a ) and experienced a total of 296 episodes. Pneumonia incidence was 900/ 1000 infant-years [95% confidence interval (CI) 800-1000] and did not differ significantly between 3-month intervals of age. Median age at first pneumonia was 127 days (IQR 60-211). Thirty-three infants were hospitalized a total of 41 times for pneumonia, corresponding to 110 hospitalizations/1000 infant-years (95% CI 80-160). Median age at first hospitalization was 150 days (IQR 63-227). Ten infants died with pneumonia at a median age of 116 days (IQR 70-149), for a total pneumonia-related mortality rate of 30/1000 infant-years (95% CI 16-57).
Breastfeeding and pneumonia among HIV-exposed uninfected infants Á sbjö rnsdó ttir et al Number of infants on whom information was available and who experienced one or more episodes of pneumonia. c Incidence of pneumonia, allowing repeat episodes and with a 14-day window for new episodes. Breastfed infants had a 74% lower risk of pneumoniarelated hospitalization [hazard ratio 0.26 (0.13-0.53); Fig. 1c ] and a trend for lower risk of pneumonia-related mortality [hazard ratio 0.32 (0.09-1.1); Fig. 1d ] compared to infants who were never breastfed.
An alternative analysis using a composite endpoint of first pneumonia or all-cause infant mortality revealed similar relationships and estimates (data not shown).
Discussion
In this study, almost half of HEU infants (46%) experienced an episode of pneumonia during the first year of life. The overall incidence of pneumonia (90/100 infant-years) was substantially higher than the estimated worldwide under-5 incidence of 29/100 child-years [4, 5] . Similarly, incidence of hospitalization (110/1000 child-years) was higher than that reported in populationbased studies in rural Kenya, which observed hospitalization rates of 48/1000 person-years among infants [7] and 7/1000 person-years among children under 5 [12] . Pneumonia-related mortality rate in our study was 30/ 1000 child-years, which is also high compared to previous reports from Kenya [13] . These differences may be partly explained by the age of our cohort -rates of pneumonia are higher in the first year of life [7] -and by increased detection, access to clinical care, and referrals for hospitalization. However, it is likely that there are true differences between our cohort and the general population of Kenyan infants as a result of maternal HIV infection; high rates of infant hospitalization have been observed in previous HEU cohorts [14] . Many factors related to maternal HIV may increase infant susceptibility to pneumonia, including compromised immunity or increased household respiratory infections; in our cohort, breastfeeding avoidance was likely a key factor.
Breastfeeding was associated with lower risk of pneumonia among HEU infants in our cohort, and the association was neither mediated by infant growth nor confounded by maternal HIV disease severity. This observation is consistent with literature supporting the role of breastfeeding in the prevention of respiratory tract infections among children in general [15] [16] [17] and in reducing infectious morbidity among HEU children [14, [18] [19] [20] . Breastfed infants have a larger thymus at 4 months of age than those not breastfed, have higher titers of neutralizing antibodies after vaccination, and may mount more effective immune responses [17] . IgA antibodies from breast milk have been suggested to protect against infection by neutralizing pathogens at mucosal surfaces [17, 21] .
Underweight infants were at 80% increased risk of pneumonia at the following visit compared to normalweight infants, consistent with previous studies [22, 23] . This may be due to increased susceptibility to infection due to malnutrition, or to increased risk of pneumonia following other acute illness [23] , which is often accompanied by weight loss [23, 24] .
Several HEU studies have noted an association between maternal CD4 þ cell count and infant hospitalization [1, 14] , mortality [14, 25] , and lower respiratory tract infection [26] . We observed an association between maternal HIV viral load and infant pneumonia, but not with CD4 þ cell count, consistent with a South African study [27] . Maternal viral load could affect infant immunity to respiratory pathogens; higher viral loads during pregnancy have been associated with decreased transplacental antibody transfer [28] .
Strengths of our study included detailed standardized characterization of serial morbidity and exposure history.
Limitations include a lack of systematic confirmatory diagnostic techniques such as chest radiographs; specificity of pneumonia diagnosis in African settings is as low as 15-40% [29, 30] . Our ability to identify predictors of pneumonia would be attenuated by misclassification of the outcome; therefore the associations we report may be underestimated. A second limitation is the potential for non-random loss to follow-up. Low birth weight [31] and prematurity [32] have been consistently found to be associated with risk of pneumonia among children in general, but we found no association. It is possible that these factors contributed to mortality before the first study visit and exclusion from this analysis. We do not have an HIV-unexposed comparison cohort and thus cannot estimate contribution of HIV exposure to incidence of pneumonia. Finally, the study was conducted prior to addition of Hib and pneumococcal vaccines to the Kenyan vaccination schedule. Although these would be expected to decrease incidence of pneumonia, approximately 50% of pneumonias are estimated to be caused by other pathogens [4, 7] and the cofactors we identified likely remain relevant to HEU infants.
As the population of HEU infants increases, understanding the increased vulnerability of this population will be critical for optimizing child health. WHO 2010 guidelines recommend that HIV-infected mothers breastfeed with either extended maternal ART or infant prophylaxis [33] . Our study suggests that in addition to enhanced prevention of infant HIV and improved maternal health resulting from maternal ART, these guidelines may lead to decreased pneumonia among HEU infants, both through reducing maternal viral load and by allowing safe extended breastfeeding.
